MyChesCo on MSN13h
Cencora to Announce Q2 Fiscal 2025 Results on May 7
CONSHOHOCKEN, PA — Cencora, Inc. (NYSE: COR) has announced it will release its Second Quarter Fiscal 2025 financial results ...
Drug Store News13d
Alto, Cencora team up to optimize patient experience for specialty medications
“Alto helps our partners elevate the patient experience, improve medication access and set new standards for convenience, ...
Morningstar4d
Cencora Announces Date and Time for Second Quarter Fiscal 2025 Earnings Release
Cencora, Inc. (NYSE: COR) today announced that it plans to release its results for the Second Quarter of Fiscal 2025 on Wednesday, May 7, 2025, prior to the opening of trading on the New York ...
Nasdaq17d
What Analysts Are Saying About Cencora Stock
Cencora (NYSE:COR) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. Summarizing their recent assessments, the table ...
Business Insider1mon
Cencora price target raised to $280 from $270 at Argus
Argus analyst David Toung raised the firm’s price target on Cencora (COR) to $280 from $270 and keeps a Buy rating on the shares. The company delivered strong results for Q1 and expects topline ...